SMS1-IN-1;SAPA-1j;SAPA-1j N-(4-bromobenzyl)-2-(4-(N-phenethylsulfamoyl)phenoxy)acetamide;atherosclerosis,SMS-1-IN-1,SMS1 IN 1,inhibit,SM biosynthetic,Inhibitor,SMS1IN1;Acetamide, N-[(4-bromophenyl)methyl]-2-[4-[[(2-phenylethyl)amino]sulfonyl]phenoxy]-;SMS1-IN-1, 10 mM in DMSO;N-[(4-bromophenyl)methyl]-2-[4-(2-phenylethylsulfamoyl)phenoxy]acetamide
SMS1-IN-1 is a potent and novel inhibitor of sphingomyelin synthase 1 (SMS1) with an IC50 value of 2.1 μM; it has potential for research related to atherosclerosis.